hims glp-1 california & Hers projects $2.3B in 2025 revenue despite uncertainty Hims & Hers Weight Loss

Monitoring helps catch these problems early instead of assuming everything is fine because body weight is going down.

PHILADELPHIA (WPVI) -- GLP-1 medications remain one of the most popular weight loss drugs on the market, but new research suggests consistency may be key to maintaining their effectiveness

As in the case of GLP-1RA, the significance of this finding which is reversible with discontinuation of therapy is unclear

As a physician in Obesity Medicine, having managed patients on GLP-1 therapies for over a decade across both the US and India, a few thoughts to gently add

This makes them strong options for patients with limited insurance coverage for GLP-1 therapies or those seeking an effective, more cost-conscious alternative

Full disclaimer included at the end of this article